Inventor · disambiguated record
Philippe Sansonetti
Also filed as: SANSONETTI PHILIPPE · SANSONETTI PHILIPPE J · SANSONETTI PHILIPPE JOSEPH
21 granted patents·10 pending applications·118 citations·filing 1985–2019
94Inventor score
Top patents by PatentIndex Score
31 records- 0178US4816389AProbe for DNA and a process for the detection of "shigellae" and entero-invasive strains of Escherichia coliPASTEUR INSTITUT·Filed 1985·Granted Mar 28, 1989·42 cites·2 claims
- 0271US9382299B2Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereofMARTEYN BENOIT·Filed 2012·Granted Jul 5, 2016·2 cites·11 claims
- 0370US10138280B2Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereofPASTEUR INSTITUT·Filed 2016·Granted Nov 27, 2018·1 cites·17 claims
- 0469US8815239B2Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and XMULARD LAURENCE·Filed 2008·Granted Aug 26, 2014·3 cites·19 claims
- 0566US7892772B2Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteinsITI SCOTLAND LTD·Filed 2007·Granted Feb 22, 2011·2 cites·4 claims
- 0665US7138126B2Transformed ShigellaPASTEUR INSTITUT·Filed 2004·Granted Nov 21, 2006·3 cites·39 claims
- 0764US7396812B2Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jul 8, 2008·3 cites·15 claims
- 0864US7078165B2Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jul 18, 2006·3 cites·26 claims
- 0964US6136542AMethod for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteriaPASTEUR INSTITUT·Filed 1999·Granted Oct 24, 2000·18 cites·16 claims
- 1063US7439053B2Transformed ShigellaPASTEUR INSTITUT·Filed 2006·Granted Oct 21, 2008·0 cites·11 claims
- 1161US11725183B2Method of culturing segmented filamentous bacteria in vitroPASTEUR INSTITUT·Filed 2019·Granted Aug 15, 2023·0 cites·12 claims
- 1261US9663833B2Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolutionMHLANGA MUSA·Filed 2008·Granted May 30, 2017·1 cites·22 claims
- 1361US8124380B2Glycoconjugates and their use as potential vaccines against infection by Shigella flexneriPHALIPON ARMELLE·Filed 2004·Granted Feb 28, 2012·6 cites·12 claims
- 1456US2009017073A1Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereofINST NAT SANTE RECH MED·Filed 2008·Application pending·0 cites
- 1556US2015343018A1Nod2-dependent pathway of cytoprotection of stem cellsPASTEUR INSTITUT·Filed 2013·Application pending·0 cites
- 1654US6528061B1Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositionsPASTEUR INSTITUT·Filed 1998·Granted Mar 4, 2003·16 cites·2 claims
- 1754US2010322974A1Targeting the histone code as a bacterial strategy for selectively modulating gene expressionPASTEUR INSTITUT·Filed 2008·Application pending·0 cites
- 1853US2017296621A1Nod2-dependent pathway of cytoprotection of stem cellsPASTEUR INSTITUT·Filed 2017·Application pending·0 cites
- 1952US2019017026A1Method and device for conserving viable and functional human polymorphonuclear neutrophilsPASTEUR INSTITUT·Filed 2018·Application pending·0 cites
- 2051US10376593B2Glycoconjugates and their use as potential vaccines against infection by Shigella flexneriPASTEUR INSTITUT·Filed 2013·Granted Aug 13, 2019·0 cites·18 claims
- 2150US10087242B2Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and XPASTEUR INSTITUT·Filed 2014·Granted Oct 2, 2018·0 cites·3 claims
- 2248US4992364AProbe for DNA and a process for the detection of "Shigellae" and entero-invasive strains of Escherichia coliPASTEUR INSTITUT·Filed 1989·Granted Feb 12, 1991·10 cites·11 claims
- 2347US9446109B2Glycoconjugates and their use as potential vaccines against infection by Shigella flexneriPHALIPON ARMELLE·Filed 2011·Granted Sep 20, 2016·0 cites·19 claims
- 2445US2016047810A1Methods to obtain a novel class of gram negative bacteria antibiotics which target an unknown cell division associated protein lop1PASTEUR INSTITUT·Filed 2014·Application pending·0 cites
- 2543US2010196391A1Shigella ipad protein and its use as a vaccine against shigella infectionALLAOUI ADBELMOUNAAIM·Filed 2007·Application pending·0 cites
- 2643US2017051253A1Method and device for conserving viable and functional human polymorphonuclear neutrophilsPASTEUR INSTITUT·Filed 2015·Application pending·0 cites
- 2742US8092989B2Targeting the histone code as a bacterial strategy for selectively modulating gene expressionARBIBE LAURENCE·Filed 2006·Granted Jan 10, 2012·0 cites·15 claims
- 2842US2003124143A1Methods for selecting immunogenic polypeptidesFiled 2002·Application pending·0 cites
- 2941US2005287612A1CARD-4 molecules and uses thereofBERTIN JOHN·Filed 2004·Application pending·0 cites
- 3038US5762941AModified shigella having reduced pathogenicityPASTEUR INSTITUT·Filed 1993·Granted Jun 9, 1998·8 cites·5 claims
- 3126US6696249B1Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteriaPASTEUR INSTITUT·Filed 1999·Granted Feb 24, 2004·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Sansonetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →